EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proteomic study identifies Aurora-A–mediated regulation of alternative splicing through multiple splicing factors

Arun Prasath Damodaran, Olivia Gavard, Jean-Philippe Gagné, Malgorzata Ewa Rogalska, Amit K Behera, Estefania Mancini, Giulia Bertolin, Thibault Courtheoux, Bandana Kumari, Justine Cailloce, Agnès Mereau, Guy G Poirier und 4 weitere

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2024.108000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Arun Prasath Damodaran und 15 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, Équipe labellisée LNCC 2014, Rennes, France; RNA Biology Laborato…. Hauptthemen laut MEDLINE: Alternative Splicing, Aurora Kinase A, Proteomics, RNA Splicing Factors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Spain Ministry of Science and Innovation, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cell cycle regulator Aurora-A kinase presents an attractive target for cancer therapies, though its inhibition is also associated with toxic side effects. To gain a more nuanced understanding of Aurora-A function, we applied shotgun proteomics to identify 407 specific protein partners, including several splicing factors. Supporting a role in alternative splicing, we found that Aurora-A localizes to nuclear speckles, the storehouse of splicing proteins. Aurora-A interacts with and phosphorylates splicing factors both in vitro and in vivo, suggesting that it regulates alternative splicing by modulating the activity of these splicing factors. Consistently, Aurora-A inhibition significantly impacts the alternative splicing of 505 genes, with RNA motif analysis revealing an enrichment for Aurora-A interacting splicing factors. Additionally, we observed a significant positive correlation between the splicing events regulated by Aurora-A and those modulated by its interacting splicing factors. An interesting example is represented by CLK1 exon 4, which appears to be regulated by Aurora-A through SRSF3. Collectively, our findings highlight a broad role of Aurora-A in the regulation of alternative splicing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingAurora Kinase AProteomicsRNA Splicing FactorsHumansSerine-Arginine Splicing FactorsHeLa CellsProtein-Tyrosine KinasesPhosphorylationProtein Serine-Threonine KinasesHEK293 CellsExons

Stichwörter der Autor:innen

Aurora-ACLK1RNASR proteincancercell cyclehnRNP proteinskinasemitosisproteomicssplicing

Substanzen

Aurora Kinase ASerine-Arginine Splicing FactorsClk dual-specificity kinasesRNA Splicing FactorsSRSF3 protein, humanProtein-Tyrosine KinasesAURKA protein, humanProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Univ Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, Équipe labellisée LNCC 2014, Rennes, France; RNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI),…
  • Univ Rennes, CNRS, Institut de Génétique et Développement de Rennes (IGDR) UMR6290, Équipe labellisée LNCC 2014, Rennes, France.
  • Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, Quebec, Canada; CHU de Québec Research Center, CHUL Pavilion, Oncology Division, Québec City, Qu…
  • Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • RNA Biology Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Frederick, Maryland, USA.
  • Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Institut Catalá de Recerca i Estudis Avançats (ICREA), Barcelon…

Förderung

  • Intramural NIH HHS
  • Spain Ministry of Science and Innovation
  • National Cancer Institute
  • National Institutes of Health
  • European Molecular Biology Laboratory
  • National Cancer Association
  • Ministerio de Ciencia e Innovación
  • Université de Rennes 1

Zitieren

APA

Damodaran, A. P., Gavard, O., Gagné, J. P., Rogalska, M. E., Behera, A. K., Mancini, E., Bertolin, G., Courtheoux, T., Kumari, B., Cailloce, J., Mereau, A., Poirier, G. G., Valcárcel, J., Gonatopoulos-Pournatzis, T., Watrin, E., & Prigent, C. (2025). Proteomic study identifies Aurora-A–mediated regulation of alternative splicing through multiple splicing factors. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.108000

Vancouver

Damodaran AP, Gavard O, Gagné JP, Rogalska ME, Behera AK, Mancini E, et al. Proteomic study identifies Aurora-A–mediated regulation of alternative splicing through multiple splicing factors. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2024.108000

BibTeX
@article{Damodaran2025,
  author = {Damodaran, Arun Prasath and Gavard, Olivia and Gagné, Jean-Philippe and Rogalska, Malgorzata Ewa and Behera, Amit K and Mancini, Estefania and Bertolin, Giulia and Courtheoux, Thibault and Kumari, Bandana and Cailloce, Justine and Mereau, Agnès and Poirier, Guy G and Valcárcel, Juan and Gonatopoulos-Pournatzis, Thomas and Watrin, Erwan and Prigent, Claude},
  title = {Proteomic study identifies Aurora-A–mediated regulation of alternative splicing through multiple splicing factors},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2024.108000}
}
Kostenlos starten →